Skip to main content

Table 2 Comparisons of patient characteristics between adequate and inadequate inhalation groups after repeated inhalations

From: Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza

Inhalation repeats

I

II

III

IV

Groups by inhalation

Adequate

Inadequate

Adequate

Inadequate

Adequate

Inadequate

Adequate

Inadequate

(n = 19)

(n = 45)

(n = 35)

(n = 29)

(n = 46)

(n = 18)

(n = 49)

(n = 15)

Age (years)

10 [5-14]

9 [5-15]

10 [5-15]

9 [5-14]*

10 [5-15]

7 [5-13]*

10 [5-15]

7 [5-13]*

Male

15 (79)

22 (49)*

26 (74)

11 (38)*

31 (67)

6 (33)*

31 (63)

6 (40)

Rohrer index (kg/cm3)

134 [83-188]

125 [98-246]

128 [83-246]

126 [98-190]

126 [83-246]

127 [100-190]

126 [83-246]

127 [100-190]

Body temperature (°C)

38.4 [35.9-40.4]

38.4 [35.8-40.3]

38.4 [35.9-40.4]

38.5 [35.8-40.1]

38.4 [35.9-40.4]

38.5 [35.8-40.0]

38.4 [35.9-40.4]

38.5 [35.8-40.0]

History of asthma

2 (11)

9 (20)

7 (20)

4 (14)

10 (22)

1 (6)

10 (20)

10 (67)

Pulse rate (beats/min)

116 [88-143]

115 [73-150]

114 [73-143]

117 [77-150]

114 [73-143]

119 [77-150]

114 [73-143]

119 [77-150]

Respiratory rate (breaths/min)

19 [14-35]

25 [14-50]*

22 [14-50]

25 [14-37]

23 [14-50]

26 [18-37]

23 [14-50]

26 [18-37]

SpO2 (%)

96 [94-98]

97 [93-99]

96 [94-99]

97 [93-99]

96 [93-99]

97 [94-99]

96 [93-99]

97 [94-99]

PIF (L/min)

150 [80-240]

110 [40-230]*

140 [80-240]

100 [40-200]*

130 [80-240]

85 [40-150]*

130 [80-240]

85 [40-150]*

  1. Values are presented as median [range] or number (%). Statistical analyses were performed using Fisher’s exact test or Mann-Whitney U-test. *: P < 0.05. SpO2: peripheral arterial oxygen saturation, PIF peak inspiratory flow